Cipla Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cipla Ltd with three other
companies in this sector in India:
Dr.Reddy's Laboratories Ltd
sales of 148.19 billion Indian Rupees [US$2.31 billion]
of which 81%
Aurobindo Pharma Ltd
(121.21 billion Indian Rupees [US$1.89 billion]
Cadila Healthcare Ltd
(86.51 billion Indian Rupees [US$1.35 billion]
of which 100%
was Pharmaceutical Products).
Cipla Ltd reported sales of 113.45 billion Indian Rupees (US$1.77 billion)
March of 2015.
increase of 12.3%
versus 2014, when the company's sales were 101.00 billion Indian Rupees.
Sales at Cipla Ltd have increased during each of the previous five years
(and since 2010, sales have increased a total of 112%).